Immune dysfunction in Niemann-Pick disease type C

Journal of Neurochemistry

Volumn 136, Issue , 2016, Pages 74-80

  Platt, Nick ^a   Speak, Annelise O ^a,b   Colaco, Alexandria ^a   Gray, James ^a   Smith, David A ^a   Williams, Ian M ^a   Wallom, Kerri Lee ^a   Platt, Frances M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

cytokine; inflammation; lysosomal storage disease; lysosome; microglia; neurodegeneration; Niemann Pick type C

Indexed keywords

ANIMAL; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; NIEMANN-PICK DISEASE, TYPE C;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; NIEMANN-PICK DISEASE, TYPE C;

EID: 84956583677     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13138     Document Type: Review

References (69)

1. Allan S. M., and, Rothwell N. J., (2001) Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734-744.
2. Ballabio A., and, Gieselmann V., (2009) Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta 1793, 684-696.
3. Baudry M., Yao Y., Simmons D., Liu J., and, Bi X., (2003) Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp. Neurol. 184, 887-903.
4. Bellettato C. M., and, Scarpa M., (2010) Pathophysiology of neuropathic lysosomal storage disorders. J. Inherit. Metab. Dis. 33, 347-362.
5. Bendelac A., Savage P. B., and, Teyton L., (2007) The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336.
6. Borbon I., Totenhagen J., Fiorenza M. T., Canterini S., Ke W., Trouard T., and, Erickson R. P., (2012) Niemann-Pick C1 mice, a model of "juvenile Alzheimer's disease", with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration. J. Alzheimers Dis. 30, 875-887.
7. Brennan P. J., Brigl M., and, Brenner M. B., (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13, 101-117.
8. Brown D. E., Thrall M. A., Walkley S. U., Wenger D. A., Mitchell T. W., Smith M. O., Royals K. L., March P. A., and, Allison R. W., (1994) Feline Niemann-Pick disease type C. Am. J. Pathol. 144, 1412-1415.
9. Butcher E. C., and, Picker L. J., (1996) Lymphocyte homing and homeostasis. Science 272, 60-66.
10. Chen F. W., Li C., and, Ioannou Y. A., (2010) Cyclodextrin induces calcium-dependent lysosomal exocytosis. PLoS ONE 5, e15054.
11. Chen X., Wang X., Keaton J. M., Reddington F., Illarionov P. A., Besra G. S., and, Gumperz J. E., (2007) Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J. Immunol. 178, 6181-6190.
12. Chovatiya R., and, Medzhitov R., (2014) Stress, inflammation, and defense of homeostasis. Mol. Cell 54, 281-288.
13. Cologna S. M., Cluzeau C. V., Yanjanin N. M., et al,. (2014) Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1. J. Inherit. Metab. Dis. 37, 83-92.
14. Cologna S. M., Jiang X. S., Backlund P. S., et al,. (2012) Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight. PLoS ONE 7, e47845.
15. Cox T. M., and, Cachon-Gonzalez M. B., (2012) The cellular pathology of lysosomal diseases. J. Pathol. 226, 241-254.
16. Cyster J. G., and, Schwab S. R., (2012) Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94.
17. Davies J. P., Chen F. W., and, Ioannou Y. A., (2000) Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science 290, 2295-2298.
18. Davis L. C., Morgan A. J., Chen J. L., et al,. (2012) NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing. Curr. Biol. 22, 2331-2337.
19. Dixit S. S., Jadot M., Sohar I., Sleat D. E., Stock A. M., and, Lobel P., (2011) Loss of Niemann-Pick C1 or C2 protein results in similar biochemical changes suggesting that these proteins function in a common lysosomal pathway. PLoS ONE 6, e23677.
20. Futerman A. H., and, van Meer G., (2004) The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5, 554-565.
21. Gadola S. D., Silk J. D., Jeans A., et al,. (2006) Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203, 2293-2303.
22. Gapin L., Matsuda J. L., Surh C. D., and, Kronenberg M., (2001) NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2, 971-978.
23. Gonzalez-Scarano F., and, Baltuch G., (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219-240.
24. Griffiths M. R., Gasque P., and, Neal J. W., (2009) The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J. Neuropathol. Exp. Neurol. 68, 217-226.
25. Higgins M. E., Davies J. P., Chen F. W., and, Ioannou Y. A., (1999) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol. Genet. Metab. 68, 1-13.
26. Jeyakumar M., Thomas R., Elliot-Smith E., et al,. (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126, 974-987.
27. Jmoudiak M., and, Futerman A. H., (2005) Gaucher disease: pathological mechanisms and modern management. Br. J. Haematol. 129, 178-188.
28. Kennedy B. E., Madreiter C. T., Vishnu N., Malli R., Graier W. F., and, Karten B., (2014) Adaptations of energy metabolism associated with increased levels of mitochondrial cholesterol in Niemann-Pick type C1-deficient cells. J. Biol. Chem. 289, 16278-16289.
29. Kono H., and, Rock K. L., (2008) How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289.
30. Lanier L. L., (2008) Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8, 259-268.
31. Lloyd-Evans E., Morgan A. J., He X., et al,. (2008) Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14, 1247-1255.
32. Loftus S. K., Morris J. A., Carstea E. D., et al,. (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277, 232-235.
33. Lopez M. E., and, Scott M. P., (2013) Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C. Dis. Models Mech. 6, 1089-1100.
34. Maceyka M., and, Spiegel S., (2014) Sphingolipid metabolites in inflammatory disease. Nature 510, 58-67.
35. Mendiratta S. K., Martin W. D., Hong S., Boesteanu A., Joyce S., and, Van Kaer L., (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6, 469-477.
36. Millat G., Marcais C., Rafi M. A., Yamamoto T., Morris J. A., Pentchev P. G., Ohno K., Wenger D. A., and, Vanier M. T., (1999) Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am. J. Hum. Genet. 65, 1321-1329.
37. 2+ signalling in health and disease. Biochem. J. 439, 349-374.
38. Napoli I., and, Neumann H., (2009) Microglial clearance function in health and disease. Neuroscience 158, 1030-1038.
39. Napoli I., and, Neumann H., (2010) Protective effects of microglia in multiple sclerosis. Exp. Neurol. 225, 24-28.
40. Olofsson P. S., Rosas-Ballina M., Levine Y. A., and, Tracey K. J., (2012) Rethinking inflammation: neural circuits in the regulation of immunity. Immunol. Rev. 248, 188-204.
41. Palin K., Cunningham C., Forse P., Perry V. H., and, Platt N., (2008) Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol. Dis. 30, 19-29.
42. Parra J., Klein A. D., Castro J., Morales M. G., Mosqueira M., Valencia I., Cortes V., Rigotti A., and, Zanlungo S., (2011) Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology. Biochem. Biophys. Res. Commun. 413, 400-406.
43. Pekny M., and, Nilsson M., (2005) Astrocyte activation and reactive gliosis. Glia 50, 427-434.
44. Perry V. H., Newman T. A., and, Cunningham C., (2003) The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4, 103-112.
45. Platt F. M., (2014) Sphingolipid lysosomal storage disorders. Nature 510, 68-75.
46. Platt F. M., Boland B., and, van der Spoel A. C., (2012) The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J. Cell Biol. 199, 723-734.
47. Platt F. M., Wassif C., Colaco A., Dardis A., Lloyd-Evans E., Bembi B., and, Porter F. D., (2014) Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease. Annu. Rev. Genomics Hum. Genet. 15, 173-194.
48. Pressey S. N., Smith D. A., Wong A. M., Platt F. M., and, Cooper J. D., (2012) Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiol. Dis. 45, 1086-1100.
49. Ransohoff R. M., and, Perry V. H., (2009) Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145.
50. Ribeiro I., Marcao A., Amaral O., Sa Miranda M. C., Vanier M. T., and, Millat G., (2001) Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations. Hum. Genet. 109, 24-32.
51. Rodriguez-Lafrasse C., Rousson R., Pentchev P. G., Louisot P., and, Vanier M. T., (1994) Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders. Biochim. Biophys. Acta 1226, 138-144.
52. Rosenbaum A. I., and, Maxfield F. R., (2011) Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J. Neurochem. 116, 789-795.
53. Schultz M. L., Tecedor L., Chang M., and, Davidson B. L., (2011) Clarifying lysosomal storage diseases. Trends Neurosci. 34, 401-410.
54. Settembre C., Fraldi A., Medina D. L., and, Ballabio A., (2013) Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14, 283-296.
55. Shen D., Wang X., Li X., et al,. (2012) Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat. Commun. 3, 731.
56. Smith D., Wallom K. L., Williams I. M., Jeyakumar M., and, Platt F. M., (2009) Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1. Neurobiol. Dis. 36, 242-251.
57. Speak A. O., Cerundolo V., and, Platt F. M., (2008) CD1d presentation of glycolipids. Immunol. Cell Biol. 86, 588-597.
58. Speak A. O., Platt N., Salio M., et al,. (2012) Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C. Eur. J. Immunol. 42, 1886-1892.
59. Speak A. O., Te Vruchte D., Davis L. C., et al,. (2014) Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. Blood 123, 51-60.
60. Stein V. M., Crooks A., Ding W., et al,. (2012) Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. J. Neuropathol. Exp. Neurol. 71, 434-448.
61. Tamari F., Chen F. W., Li C., Chaudhari J., and, Ioannou Y. A., (2013) PKC activation in Niemann pick C1 cells restores subcellular cholesterol transport. PLoS ONE 8, e74169.
62. Vanier M. T., (2010) Niemann-Pick disease type C. Orphanet J. Rare Dis. 5, 16.
63. Vitner E. B., Platt F. M., and, Futerman A. H., (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J. Biol. Chem. 285, 20423-20427.
64. Vivier E., Raulet D. H., Moretta A., Caligiuri M. A., Zitvogel L., Lanier L. L., Yokoyama W. M., and, Ugolini S., (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49.
65. Walter M., Chen F. W., Tamari F., Wang R., and, Ioannou Y. A., (2009) Endosomal lipid accumulation in NPC1 leads to inhibition of PKC, hypophosphorylation of vimentin and Rab9 entrapment. Biol. Cell 101, 141-152.
66. Walzer T., Chiossone L., Chaix J., et al,. (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 8, 1337-1344.
67. Wassif C. A., Cross J. L., Iben J., et al,. (2015) High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C prediced by analysis of massively parallel sequencing data sets. Genet. Med. doi:1038/gim.2015.25 [Epub ahead of print].
68. Williams I. M., Wallom K. L., Smith D. A., Al Eisa N., Smith C., and, Platt F. M., (2014) Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol. Dis. 67, 9-17.
69. Zhang M., Strnatka D., Donohue C., Hallows J. L., Vincent I., and, Erickson R. P., (2008) Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1-/- mice. J. Neurosci. Res. 86, 2848-2856.